Natalie S. Grover

University of North Carolina at Chapel Hill

Also affiliated with UNC Lineberger Comprehensive Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma”.

Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma

Blood Advances(2021)10.1182/bloodadvances.2021005385

N/A

1.6DataRank · unranked

48 citations

Beibo Zhao, Jorge D. Oldan, George Hucks, Amir H. Khandani, Christopher Dittus +12 more

Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2)

PLOS Digital Health(2023)10.1371/journal.pdig.0000178

N/A

0.495DataRank · unranked

11 citations

Deepika Dilip, Andriy Derkach, Natalie S. Grover, Olivier Elemento, Ross L. Levine +11 more

Older patients with mantle cell lymphoma (MCL): Practice patterns and predictors of survival in the rituximab era.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e20064

N/A

0DataRank · unranked

0 citations

Jeffrey M. Switchenko, Subir Goyal, Veronika Bachanová, James N. Gerson, Stefan K. Barta +15 more

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Blood(2021)10.1182/blood.2021012888

N/A

0DataRank · unranked

95 citations

Daniel Reed, Ashley McCook, Jeremy Sen, Christian Barlow, Mary‐Kate Malecek +48 more

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Blood Advances(2021)10.1182/bloodadvances.2021004765

N/A

0DataRank · unranked

41 citations

Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski, Alina S. Gerrie +30 more

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2022009225

N/A

0DataRank · unranked

11 citations

Jeffrey M. Switchenko, Veronika Bachanová, James N. Gerson, Stefan K. Barta, Max J. Gordon +30 more

The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma

Journal of Personalized Medicine(2022)10.3390/jpm12020197

N/A

0DataRank · unranked

10 citations

Barbara Savoldo, Natalie S. Grover, Jeremy A. Meier

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022008916

N/A

0DataRank · unranked

29 citations

Subir Goyal, Jeffrey M. Switchenko, Jason T. Romancik, Manali Kamdar, Irl Brian Greenwell +17 more

Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2)

UNC Libraries(2023)10.17615/6tfk-xx56

N/A

0DataRank · unranked

0 citations

Jacob L. Glass, John A. Batsis, Andriy Derkach, Olivier Elemento, Charlotte Bailey +11 more

CD19-directed CART therapy for T-cell/histiocyte–rich large B-cell lymphoma

Blood Advances(2024)10.1182/bloodadvances.2024013863

N/A

0DataRank · unranked

21 citations

Joshua Fein, Kwang Woo Ahn, Molly Allbee-Johnson, Nausheen Ahmed, Farrukh T. Awan +14 more

Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in Adults

medRxiv(2024)10.1101/2024.07.10.24310235

N/A

0DataRank · unranked

1 citations

Yueling Xiu, Michael Mohnasky, Jonathan S. Serody, Paul M. Armistead, Gianpietro Dotti +13 more

Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis

UNC Libraries(2024)10.17615/d5s2-9s76

N/A

0DataRank · unranked

0 citations

Peter A. Riedell, R. Alejandro Sica, Tania Jain, Brian T. Hill, Craig S. Sauter +24 more

Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

Blood Advances(2025)10.1182/bloodadvances.2025016141

N/A

0DataRank · unranked

15 citations

Megan M. Herr, Min Chen, Michael J. Martens, John H. Baird, Lohith Gowda +32 more

141 | CD30 CAR‐T IN RELAPSED AND REFRACTORY CD30+ LYMPHOMAS: LONG‐TERM FOLLOW‐UP OF A PHASE IB/II CLINICAL TRIAL

Hematological Oncology(2025)10.1002/hon.70093_141

N/A

0DataRank · unranked

2 citations

Catherine Cheng, Caroline Babinec, Danielle Burton, John B. West, K. Morrison +13 more

Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in Adults

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf541

N/A

0DataRank · unranked

1 citations

Yueling Xiu, Michael Mohnasky, Jonathan S. Serody, Paul M. Armistead, Gianpietro Dotti +13 more

Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapy

Blood Advances(2020)10.1182/bloodadvances.2020003218

N/A

0DataRank · unranked

33 citations

Nilanjan Ghosh, Natalie S. Grover, Jared Block, Catherine Cheng, Kaitlin Morrison +6 more

Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma

Haematologica(2025)10.3324/haematol.2025.288946

N/A

0DataRank · unranked

0 citations

Thomas Ollila, Dai Chihara, Geoffrey Shouse, Natalie S. Grover, Reem Karmali +7 more

A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma

UNC Libraries(2020)10.17615/13z1-e994

N/A

0DataRank · unranked

4 citations

Steven I. Park, Thomas C. Shea, James G. Wall, Kristy L. Richards, Matthew C. Foster +7 more